John Lambert, Ph.D.
ADC Development
Inventor of Kadcyla® and ElahereTM
ADC Development
Inventor of Kadcyla® and ElahereTM
[Education and Experience]
- Ph.D. in Biochemistry, University of Cambridge, UK
- University of California at Davis, CA, Post-Doc (1976-1980)
- University of Glasgow, Scotland, UK, Post-Doc (1980-1982)
- Dana-Farber Cancer Institute (1982-1987)
- ImmuoGen, Inc. (1987-2017), retired as a Executive Vice President
- Scientific Advisory Board member at many biotech companies (2003-present)
[Honors and Awards]
- 1988, Pierce Immunotoxin Award
- 2013, Champions in Healthcare, Innovator/Research, Boston Business Journal
- 2016, Winner of World ADC Awards for Long-standing Contribution to the Field
- 2016, Elected a Fellow of the American Institute for Medical and Biological Engineering(AIMBE)
- 2017, Power List of Most Influential Peaple in Drug Development, The Medicine Maker
- 2018, Appointed Honorary Professor, Queen's University, Belfast, NI, UK